Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder

Clinical trial NCT00380692 · COMPLETED

Trial details

NCT number: NCT00380692
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Autistic Disorder Attention Deficit Disorder With Hyperactivity

Start date: 2006-10-01
Primary completion: 2008-05-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.